Characterization of the post-translational modification of recombinant human BMP-15 mature protein

Protein Science

Volumn 17, Issue 2, 2008, Pages 362-370

  Saito, Seiji ^a   Yano, Keiichi ^a   Sharma, Shweta ^b   Mcmahon, Heather E ^b   Shimasaki, Shunichi ^b,c  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Bone morphogenetic protein; Mass spectrometry; Neutral loss scan; O glycosylation; Phosphorylation; Post translational modification; Proteomics analysis; Pyroglutamic acid

Indexed keywords

BONE MORPHOGENETIC PROTEIN 15; RECOMBINANT PROTEIN;

AMINO TERMINAL SEQUENCE; ARTICLE; CONTROLLED STUDY; FEMALE FERTILITY; HUMAN; HUMAN CELL; MATRIX ASSISTED LASER DESORPTION IONIZATION TIME OF FLIGHT MASS SPECTROMETRY; NUCLEOTIDE SEQUENCE; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN MODIFICATION; PROTEIN STRUCTURE;

AMINO ACID SEQUENCE; ANIMALS; GLYCOSYLATION; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MOLECULAR SEQUENCE DATA; PHOSPHORYLATION; PROTEIN PROCESSING, POST-TRANSLATIONAL; RECOMBINANT PROTEINS; SEQUENCE ALIGNMENT;

EID: 38649116901     PISSN: 09618368     EISSN: 1469896X     Source Type: Journal    
DOI: 10.1110/ps.073232608     Document Type: Article

References (51)

1. Bennett, H.P., Brubaker, P.L., Seger, M.A., and Solomon, S. 1983. Human phosphoserine 31 corticotropin1-39. Isolation and characterization. J. Biol. Chem. 258: 8108-8112.
2. Brunati, A.M., Contri, A., Muenchbach, M., James, P., Marin, O., and Pinna, L.A. 2000. Grp94 (endoplasmin) co-purifies with and is phosphorylated by Golgi apparatus casein kinase. FEBS Lett. 471: 151-155.
3. Carabatsos, M.J., Elvin, J., Matzuk, M.M., and Albertini, D.F. 1998. Characterization of oocyte and follicle development in growth differentiation factor-9-deficient mice. Dev. Biol. 204: 373-384.
4. Desmond, H., Varro, A., Young, J., Gregory, H., Nemeth, J., and Dockray, G.J. 1989. The constitution and properties of phosphorylated and unphosphorylated C-terminal fragments of progastrin from dog and ferret antrum. Regul. Pept. 25: 223-233.
5. Dockray, G.J., Varro, A., Desmond, H., Young, J., Gregory, H., and Gregory, R.A. 1987. Post-translational processing of the porcine gastrin precursor by phosphorylation of the COOH-terminal fragment. J. Biol. Chem. 262: 8643-8647.
6. Dong, J., Albertini, D.F., Nishimori, K., Kumar, T.R., Lu, N., and Matzuk, M. 1996. Growth differentiation factor-9 is required during early ovarian folliculogenesis. Nature 383: 531-535.
7. Dube, J.L., Wang, P., Elvin, J., Lyons, K.M., Celeste, A.J., and Matzuk, M.M. 1998. The bone morphogenetic protein 15 gene is X-linked and expressed in oocytes. Mol. Endocrinol. 12: 1809-1817.
8. Eipper, B.A. and Mains, R.E. 1982. Phosphorylation of pro-adrenocorticotropin/endorphin-derived peptides. J. Biol. Chem. 257: 4907-4915.
9. Elvin, J.A., Yan, C., and Matzuk, M.M. 2000. Oocyte-expressed TGF-β superfamily members in female fertility. Mol. Cell. Endocrinol. 159: 1-5.
10. Eppig, J.J. 2001. Oocyte control of ovarian follicular development and function in mammals. Reproduction 122: 829-838.
11. Erickson, G.F. and Shimasaki, S. 2000. The role of the oocyte in folliculogenesis. Trends Endocrinol. Metab. 11: 193-198.
12. Fares, F. 2006. The role of O-linked and N-linked oligosaccharides on the structure-function of glycoprotein hormones: Development of agonists and antagonists. Biochim. Biophys. Acta 1760: 560-567. doi: org/10.1016/j.bbagen.2005.12.022.
13. Gregory, K.E., Ono, R.N., Charbonneau, N.L., Kuo, C.L., Keene, D.R., Bachinger, H.P., and Sakai, L.Y. 2005. The prodomain of BMP-7 targets the BMP-7 complex to the extracellular matrix. J. Biol. Chem. 280: 27970-27980.
14. Harris, R.J. 1995. Processing of C-terminal lysine and arginine residues of proteins isolated from mammalian cell culture. J. Chromatogr. A 705: 129-134.
15. Hayashi, M., McGee, E.A., Min, G., Klein, C., Rose, U.M., Van Duin, M., and Hsueh, A.J.W. 1999. Recombinant growth differentiation factor-9 (GDF-9) enhances growth and differentiation of cultured early ovarian follicles. Endocrinology 140: 1236-1244.
16. Hinke, S.A., Pospisilik, J.A., Demuth, H.U., Mannhart, S., Kuhn-Wache, K., Hoffmann, T., Nishimura, E., Pederson, R.A., and McIntosh, C.H. 2000. Dipeptidyl peptidase IV (DPIV/CD26) degradation of glucagon. Characterization of glucagon degradation products and DPIV-resistant analogs. J. Biol. Chem. 275: 3827-3834.
17. Jaatinen, R., Laitinen, M., Vuojolainen, K., Aaltonen, J., Louhio, H., Heikinheimo, K., Lehtonen, E., and Ritvos, O. 1999. Localization of growth differentiation factor-9 (GDF-9) mRNA and protein in rat ovaries and cDNA cloning of rat GDF-9 and its novel homolog GDF-9b. Mol. Cell. Endocrinol. 156: 189-193.
18. Jaeken, J. and Matthijs, G. 2007. Congenital disorders of glycosylation: A rapidly expanding disease family. Annu. Rev. Genomics Hum. Genet. 8: 261-278.
19. Jiang, M.S., Liang, L.F., Wang, S., Ratovitski, T., Holmstrom, J., Barker, C., and Stotish, R. 2004. Characterization and identification of the inhibitory domain of GDF-8 propeptide. Biochem. Biophys. Res. Commun. 315: 525-531.
20. Jones, J.I., Busby Jr., W.H., Wright, G., Smith, C.E., Kimack, N.M., and Clemmons, D.R. 1993. Identification of the sites of phosphorylation in insulin-like growth factor binding protein-1. Regulation of its affinity by phosphorylation of serine 101. J. Biol. Chem. 268: 1125-1131.
21. Julenius, K., Mølgaard, A., Gupta, R., and Brunak, S. 2005. Prediction, conservation analysis, and structural characterization of mammalian mucin-type O-glycosylation sites. Glycobiology 15: 153-164.
22. Kessler, M.J., Mise, T., Ghai, R.D., and Bahl, O.P. 1979. Structure and location of the O-glycosidic carbohydrate units of human chorionic gonadotropin. J. Biol. Chem. 254: 7909-7914.
23. Laemmli, U.K. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage t4. Nature 227: 680-685.
24. Laitinen, M., Vuojolainen, K., Jaatinen, R., Ketola, I., Aaltonen, J., Lehtonen, E., Heikinheimo, M., and Ritvos, O. 1998. A novel growth differentiation factor-9 (GDF-9) related factor is co-expressed with GDF-9 in mouse oocytes during folliculogenesis. Mech. Dev. 78: 135-140.
25. Lasa, M., Chang, P.L., Prince, C.W., and Pinna, L.A. 1997. Phosphorylation of osteopontin by Golgi apparatus casein kinase. Biochem. Biophys. Res. Commun. 240: 602-605.
26. Lasa-Benito, M., Marin, O., Meggio, F., and Pinna, L.A. 1996. Golgi apparatus mammary gland casein kinase: Monitoring by a specific peptide substrate and definition of specificity determinants. FEBS Lett. 382: 149-152.
27. Lechan, R.M., Wu, P., Jackson, I.M., Wolf, H., Cooperman, S., Mandel, G., and Goodman, R.H. 1986. Thyrotropin-releasing hormone precursor: Characterization in rat brain. Science 231: 159-161.
28. Lee, S.J. and McPherron, A.C. 2001. Regulation of myostatin activity and muscle growth. Proc. Natl. Acad. Sci. 98: 9306-9311.
29. Liao, W.X., Moore, R.K., Otsuka, F., and Shimasaki, S. 2003. Effect of intracellular interactions on the processing and secretion of bone morphogenetic protein-15 (BMP-15) and growth and differentiation factor-9: Implication of the aberrant ovarian phenotype of BMP-15 mutant sheep. J. Biol. Chem. 278: 3713-3719.
30. May, L.T. and Sehgal, P.B. 1992. Phosphorylation of interleukin-6 at serine-54: An early event in the secretory pathway in human fibroblasts. Biochem. Biophys. Res. Commun. 185: 524-530.
31. McGrath, S.A., Esquela, A.F., and Lee, S.-J. 1995. Oocyte-specific expression of growth/differentiation factor-9. Mol. Endocrinol. 9: 131-136.
32. McPherron, A.C. and Lee, S.-J. 1993. GDF-3 and GDF-9: Two new members of the transforming growth factor-β superfamily containing a novel pattern of cysteines. J. Biol. Chem. 268: 3444-3449.
33. Meggio, F., Boulton, A.P., Marchiori, F., Borin, G., Lennon, D.P., Calderan, A., and Pinna, L.A. 1988. Substrate-specificity determinants for a membrane-bound casein kinase of lactating mammary gland. A study with synthetic peptides. Eur. J. Biochem. 177: 281-284.
34. Meggio, F., Perich, J.W., Meyer, H.E., Hoffmann-Posorske, E., Lennon, D.P., Johns, R.B., and Pinna, L.A. 1989. Synthetic fragments of β-casein as model substrates for liver and mammary gland casein kinases. Eur. J. Biochem. 186: 459-464.
35. Otsuka, F. and Shimasaki, S. 2002. A negative feedback system between oocyte bone morphogenetic protein 15 and granulosa cell kit ligand: Its role in regulating granulosa cell mitosis. Proc. Natl. Acad. Sci. 99: 8060-8065.
36. Otsuka, F., Yamamoto, S., Erickson, G.F., and Shimasaki, S. 2001. Bone morphogenetic protein-15 inhibits follicle-stimulating hormone (FSH) action by suppressing FSH receptor expression. J. Biol. Chem. 276: 11387-11392.
37. Otsuka, F., Yao, Z., Lee, T.H., Yamamoto, S., Erickson, G.F., and Shimasaki, S. 2000. Bone morphogenetic protein-15: Identification of target cells and biological functions. J. Biol. Chem. 275: 39523-39528.
38. Price, P.A., Rice, J.S., and Williamson, M.K. 1994. Conserved phosphorylation of serines in the Ser-X-Glu/Ser(P) sequences of the vitamin K-dependent matrix Gla protein from shark, lamb, rat, cow, and human. Protein Sci. 3: 822-830.
39. Richter, K., Kawashima, E., Egger, R., and Kreil, G. 1984. Biosynthesis of thyrotropin releasing hormone in the skin of Xenopus laevis: Partial sequence of the precursor deduced from cloned cDNA. EMBO J. 3: 617-621.
40. Seeburg, P.H. and Adelman, J.P. 1984. Characterization of cDNA for precursor of human luteinizing hormone releasing hormone. Nature 311: 666-668.
41. Seydewitz, H.H., Kaiser, C., and Witt, I. 1985. The location of a second in vivo phosphorylation site in the Aa chain of human fibrinogen. In Fibrinogen - structural variants and interactions. (ed. A. Henschen), pp. 121-132. Walter de Gruyter & Co, Berlin, Germany.
42. Shevchenko, A., Wilm, M., Vorm, O., and Mann, M. 1996. Mass spectrometric sequencing of proteins silver-stained polyacrylamide gels. Anal. Chem. 68: 850-858.
43. Shimasaki, S., Moore, R.K., Otsuka, F., and Erickson, G.F. 2004. The bone morphogenetic protein system in mammalian reproduction. Endocr. Rev. 25: 72-101.
44. Sorensen, E.S., Hojrup, P., and Petersen, T.E. 1995. Post-translational modifications of bovine osteopontin: Identification of twenty-eight phosphorylation and three O-glycosylation sites. Protein Sci. 4: 2040-2049.
45. Thies, R.S., Chen, T.J., Davies, M.V., Tomkinson, K.N., Pearson, A.A., Shakey, Q.A., and Wolfman, N.M. 2000. GDF-8 propeptide binds to GDF-8 and antagonizes biological activity by inhibiting GDF-8 receptor binding. Growth Factors 18: 251-259.
46. Tibaldi, E., Arrigoni, G., Brunati, A.M., James, P., and Pinna, L.A. 2006. Analysis of a sub-proteome which co-purifies with and is phosphorylated by the Golgi casein kinase. Cell. Mol. Life Sci. 63: 378-389.
47. Van Coillie, E., Proost, P., Van Aelst, I., Struyf, S., Polfliet, M., De Meester, I., Harvey, D.J., Van Damme, J., and Opdenakker, G. 1998. Functional comparison of two human monocyte chemotactic protein-2 isoforms, role of the amino-terminal pyroglutamic acid and processing by CD26/dipeptidyl peptidase IV. Biochemistry 37: 12672-12680.
48. Varro, A., Desmond, H., Pauwels, S., Gregory, H., Young, J., and Dockray, G.J. 1988. The human gastrin precursor. Characterization of phosphorylated forms and fragments. Biochem. J. 256: 951-957.
49. Watkinson, A., Young, J., Varro, A., and Dockray, G.J. 1989. The isolation and chemical characterization of phosphorylated enkephalin-containing peptides from bovine adrenal medulla. J. Biol. Chem. 264: 3061-3065.
50. Wells, L., Vosseller, K., Cole, R.N., Cronshaw, J.M., Matunis, M.J., and Hart, G.W. 2002. Mapping sites of O-GlcNAC modification using affinity tags for serine and threonine post-translational modifications. Mol. Cell. Proteomics 1: 791-804.
51. Yoshino, O., McMahon, H.E., Sharma, S., and Shimasaki, S. 2006. A unique preovulatory expression pattern plays a key role in the physiological functions of BMP-15 in the mouse. Proc. Natl. Acad. Sci. 103: 10678-10683.